Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve
NCT ID: NCT01888159
Last Updated: 2013-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
NCT01544049
Impact of Salpingectomy on Ovarian Reserve
NCT02284711
Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause
NCT04757922
Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section
NCT02377128
Salpingectomy During Cesarean Section
NCT02880423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilateral Salpingectomy
Salpingectomy vs Tubal Sterilisation
Bilateral Salpingectomy
Tubal Sterilization with bipolar
Salpingectomy vs Tubal Sterilisation
Tubal sterilization with bipolar energy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bilateral Salpingectomy
Tubal sterilization with bipolar energy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* family history of ovarian cancer
* presence of menopausal symptoms
* irregular cycles
* Hormone Replacement Therapy or hormone contraceptions the last 3 months
* history of previous ovarian or uterine surgeries
* imaging suggesting an ovarian cyst or other adnexal pathology during investigation
* previous salpingectomy
25 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karlstad Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leonidas Magarakis
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Obstetrics and Gynecology
Karlstad, Värmaland, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEvsTSinAMH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.